Sirolimus for the treatment of severe intestinal polyposis in patients with familial adenomatous polyposis (FAP); a pilot study.
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Sirolimus (Primary)
- Indications Familial adenomatous polyposis
- Focus Adverse reactions; Therapeutic Use
- 09 Jan 2018 Planned End Date changed from 1 May 2018 to 1 Jan 2019.
- 09 Jan 2018 Planned primary completion date changed from 1 May 2018 to 1 Jan 2019.
- 16 Dec 2016 New trial record